APA (7th ed.) Citation

Dafeng Guo, Yu Yu, Binyu Long, Ping Deng, Dongzhi Ran, Lei Han, . . . Zongjie Gan. (2022). Design, synthesis and biological evaluation of 2,4-pyrimidinediamine derivatives as ALK and HDACs dual inhibitors for the treatment of ALK addicted cancer. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Dafeng Guo, Yu Yu, Binyu Long, Ping Deng, Dongzhi Ran, Lei Han, Jiecheng Zheng, and Zongjie Gan. Design, Synthesis and Biological Evaluation of 2,4-pyrimidinediamine Derivatives as ALK and HDACs Dual Inhibitors for the Treatment of ALK Addicted Cancer. Taylor & Francis Group, 2022.

MLA (9th ed.) Citation

Dafeng Guo, et al. Design, Synthesis and Biological Evaluation of 2,4-pyrimidinediamine Derivatives as ALK and HDACs Dual Inhibitors for the Treatment of ALK Addicted Cancer. Taylor & Francis Group, 2022.